Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dechra Pharmaceuticals PLC (GB:DPH)
LSE:DPH
RESEARCH TOOLSreports
Dechra Pharmaceuticals (DPH) Share Price & Analysis
4 Followers
DPH Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range2,446.04p - 4,145.84p
Previous Close3,804p
Volume24.40K
Average Volume (3M)1.22M
Market Cap
£4.33B
Enterprise Value475.56B
Total Cash (Recent Filing)$87.90M
Total Debt (Recent Filing)$511.20M
Price to Earnings (P/E)105.3
Beta0.85
Next Earnings
Feb 26, 2024EPS EstimateN/A
Last Dividend Ex-Date
Mar 09, 2023Dividend Yield
0.45 (0.01%)Share Statistics
EPS (TTM)0.36
Shares Outstanding113,824,190
10 Day Avg. Volume360,330
30 Day Avg. Volume1,220,088
Standard Deviation0.08
R-Squared0.05
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)-1604.94
Price to Sales (P/S)1096.02
Price to Cash Flow (P/CF)4199.30
P/FCF Ratio5683.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.24K
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
3,875.00pPrice Target Upside1.87% Upside
Rating ConsensusHold
Number of Analyst Covering1
Dechra Pharmaceuticals News
DPH FAQ
What was Dechra Pharmaceuticals PLC’s price range in the past 12 months?
Dechra Pharmaceuticals PLC lowest share price was 2446.04p and its highest was 4145.84p in the past 12 months.
What is Dechra Pharmaceuticals PLC’s market cap?
Currently, no data Available
When is Dechra Pharmaceuticals PLC’s upcoming earnings report date?
Dechra Pharmaceuticals PLC’s upcoming earnings report date is Feb 26, 2024 which is in 155 days.
How were Dechra Pharmaceuticals PLC’s earnings last quarter?
Currently, no data Available
Is Dechra Pharmaceuticals PLC overvalued?
According to Wall Street analysts Dechra Pharmaceuticals PLC’s price is currently Undervalued.
Does Dechra Pharmaceuticals PLC pay dividends?
Dechra Pharmaceuticals PLC pays a Annually dividend of 12.5p which represents an annual dividend yield of 1.19%. See more information on Dechra Pharmaceuticals PLC dividends here
What is Dechra Pharmaceuticals PLC’s EPS estimate?
Dechra Pharmaceuticals PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dechra Pharmaceuticals PLC have?
Dechra Pharmaceuticals PLC has 113,888,300 shares outstanding.
What happened to Dechra Pharmaceuticals PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Dechra Pharmaceuticals PLC?
Currently, no hedge funds are holding shares in GB:DPH
---
Dechra Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
3,875.00p (1.87% Upside)
3,875.00p (1.87% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
39.95%
12-Months-Change
Fundamentals
Return on Equity
5.42%
Trailing 12-Months
Asset Growth
48.11%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Dechra Pharmaceuticals PLC
Dechra Pharmaceuticals PLC is a major drug manufacturing company with a focus on veterinary pharmaceutical products. The company develops, manufactures, and markets its products exclusively for veterinarians globally. Dechra is structured along three segments, including being European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The vast majority of Dechra's revenue is generated in Europe, followed by the U.S. Dechra derives most of its revenue through its Companion Animal Product category, followed by food-producing animal products.
---
Top 5 ETFs holding DPH
dbxt FTSE ALL-S Shs -1D- Distribution
$1.42M
Lyxor Core UK Equity All Cap (DR) UCITS ETF
$649.12K
UBS ETF FTSE100 Shs -A- Distribution
$145.39K
dbxt FTSE 100 Shs -1D- Distribution
$138.02K
dbxt FTSE 100 U Shs -1C- Capitalisation
$114.00K
Up to five ETFs with an Outperform Smart Score that hold DPH. The ETFs are listed according to market value of DPH within the ETF
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
---